Literature DB >> 30181180

p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4.

Chihiro Kajiwara1, Katsumi Fumoto1, Hirokazu Kimura1, Satoshi Nojima2, Keita Asano1, Kazuki Odagiri3, Makoto Yamasaki3, Hayato Hikita4, Tetsuo Takehara4, Yuichiro Doki3, Eiichi Morii2, Akira Kikuchi5.   

Abstract

Dickkopf3 (DKK3) is a secretory protein that belongs to the DKK family, but exhibits structural divergence from other family members, and its corresponding receptors remain to be identified. Although DKK3 has been shown to have oncogenic functions in certain cancer types, the underlying mechanism by which DKK3 promotes tumorigenesis remains to be clarified. We show here that DKK3 stimulates esophageal cancer cell proliferation via cytoskeleton-associated protein 4 (CKAP4), which acts as a receptor for DKK3. DKK3 was expressed in approximately 50% of tumor lesions of esophageal squamous cell carcinoma (ESCC) cases; simultaneous expression of DKK3 and CKAP4 was associated with poor prognosis. Anti-CKAP4 antibody inhibited both binding of DKK3 to CKAP4 and xenograft tumor formation induced by ESCC cells. p63, a p53-related transcriptional factor frequently amplified in ESCC, bound to the upstream region of the DKK3 gene. Knockdown of p63 decreased DKK3 expression in ESCC cells, and reexpression of DKK3 partially rescued cell proliferation in p63-depleted ESCC cells. Expression of ΔNp63α and DKK3 increased the size of tumor-like esophageal organoids, and anti-CKAP4 antibody inhibited growth of esophageal organoids. Taken together, these results suggest that the DKK3-CKAP4 axis might serve as a novel molecular target for ESCC.Significance: In esophageal cancer, findings identify DKK3 as a poor prognostic indicator and demonstrate CKAP4 inhibition as an effective therapeutic strategy. Cancer Res; 78(21); 6107-20. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30181180     DOI: 10.1158/0008-5472.CAN-18-1749

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  CKAP4 Regulates Cell Migration via the Interaction with and Recycling of Integrin.

Authors:  Yoshihito Osugi; Katsumi Fumoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2019-07-29       Impact factor: 4.272

2.  DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.

Authors:  Feda H Hamdan; Steven A Johnsen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

3.  Screening differentially expressed proteins from co-cultured hematopoietic cells and bone marrow-derived stromal cells by quantitative proteomics (SILAC) method.

Authors:  Rui Liu; Yi Wang; Bingxin Li; Hui Wang; Feng Guan; Zengqi Tan; Xiang Li
Journal:  Clin Proteomics       Date:  2019-07-18       Impact factor: 3.988

4.  Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells.

Authors:  Debdatta Halder; Shekhar Saha; Raman K Singh; Indranil Ghosh; Ditipriya Mallick; Sumit K Dey; Arijit Ghosh; Benu Brata Das; Somiranjan Ghosh; Siddhartha S Jana
Journal:  Mol Biol Cell       Date:  2019-04-17       Impact factor: 4.138

5.  Extrachromosomal circular DNAs are common and functional in esophageal squamous cell carcinoma.

Authors:  Zhenguo Sun; Na Ji; Renchang Zhao; Jinghui Liang; Jin Jiang; Hui Tian
Journal:  Ann Transl Med       Date:  2021-09

6.  SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC.

Authors:  You Fu; Guocai Tian; Zhiyuan Zhang; Xiao Yang
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

7.  The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.

Authors:  Hirokazu Kimura; Ryota Sada; Naoki Takada; Akikazu Harada; Yuichiro Doki; Hidetoshi Eguchi; Hideki Yamamoto; Akira Kikuchi
Journal:  Oncogene       Date:  2021-06-11       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.